Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95)+ T lymphocytes

被引:94
|
作者
Puppo, F
Contini, P
Ghio, M
Brenci, S
Scudeletti, M
Filaci, G
Ferrone, S
Indiveri, F
机构
[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy
[2] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
HLA; immunomodulation;
D O I
10.1093/intimm/12.2.195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study, we have evaluated the apoptotic effect of soluble human MHC class I (sHLA-I) antigens on CD8(+) T lymphocytes. sHLA-I antigens and beta(2)-microglobulin-free HLA class I heavy chains, isolated from serum, induced apoptosis on phytohemagglutinin-activated CD8(+) T lymphocytes in autologous and allogeneic combinations. The extent of CD8(+) T cell apoptosis depends on the degree of activation, time of incubation with sHLA-I antigens and amount of sHLA-I antigens added to the cultures. Apoptosis is induced by the interaction of Fas (CD95)(+) cells with soluble Fas ligand which is released following binding of sHLA-I antigens to CD8 molecules. These results suggest that sHLA-I antigens may regulate immune responses by inducing apoptosis in activated CD8(+) T cells.
引用
收藏
页码:195 / 203
页数:9
相关论文
共 50 条
  • [31] Serum elevations of soluble Fas (CD95/Apo-I) concur in deregulating T cell apoptosis during active lupus disease
    Silvestris, F
    Williams, RC
    Calvani, N
    Grinello, D
    Tucci, M
    Cafforio, P
    Dammacco, F
    CLINICAL AND EXPERIMENTAL MEDICINE, 2002, 2 (01) : 13 - 27
  • [32] Soluble Fas (APO-1/CD95) isoform in adult T-cell leukemia
    Kamihira, S
    Yamada, Y
    LEUKEMIA & LYMPHOMA, 2001, 41 (1-2) : 169 - 176
  • [33] Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction
    Debatin, KM
    Beltinger, C
    Bohler, T
    Fellenberg, J
    Friesen, C
    Fulda, S
    Herr, I
    Los, M
    Scheuerpflug, C
    Sieverts, H
    Stahnke, K
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : 405 - 410
  • [34] Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons
    Hosaka, N
    Oyaizu, N
    Kaplan, MH
    Yagita, H
    Pahwa, S
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (04): : 1030 - 1039
  • [35] CD95 (Fas) ligand - A mediator of cytotoxic T lymphocyte-mediated apoptosis and immune privilege
    Duke, RC
    Nash, PB
    Schleicher, MS
    Richards, C
    Moore, J
    Newell, E
    Franzusoff, A
    Bellgrau, D
    PROGRAMMED CELL DEATH, 1997, : 159 - 167
  • [36] Tumor exosomes expressing fas ligand mediate CD8+ T cell apoptosis
    C. A. O'Brien
    T. E. Ichim
    Z. Zhong
    W. P. Min
    Annals of Surgical Oncology, 2004, 11 : S91 - S91
  • [37] Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins
    Genestier, L
    Fournel, S
    Flacher, M
    Assossou, O
    Revillard, JP
    Bonnefoy-Berard, N
    BLOOD, 1998, 91 (07) : 2360 - 2368
  • [38] Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells
    Rich, RF
    Green, WR
    JOURNAL OF IMMUNOLOGY, 2002, 168 (06): : 2751 - 2758
  • [39] Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection
    Silvestris, F
    Grinello, D
    Del Prete, A
    Cafforio, P
    Quarto, M
    Dammacco, F
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (07) : 603 - 614
  • [40] Serum levels of soluble 4-1BB (CD137) ligand and soluble Fas (CD95) ligand are independent prognostic factors for disease progression in patients with MDS
    Salih, HR
    Nuessler, V
    Starling, GC
    Kiener, PA
    Schmetzer, HM
    FASEB JOURNAL, 2002, 16 (04): : A669 - A669